Article info

Download PDFPDF
Systematic review
Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect
  1. Correspondence to Mehmet Sofuoglu
    950 Campbell Avenue, Building 35, Mailcode 151-D, West Haven, CT 06516, USA; mehmet.sofuoglu{at}yale.edu
View Full Text

Citation

Sofuoglu M, Duffey D, Mooney ME
Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect

Publication history

  • First published March 9, 2011.
Online issue publication 
July 19, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.